Public knowledge of cardiovascular disease and its risk factors in Kuwait: a cross-sectional survey

Abdelmoneim Awad, Hala Al-Nafisi, Abdelmoneim Awad, Hala Al-Nafisi

Abstract

Background: Cardiovascular disease (CVD) is estimated to cause 46% of all mortalities in Kuwait. To design effective primary and secondary prevention programs, an assessment of a population's prior CVD knowledge is of paramount importance. There is scarcity of data on the existing CVD knowledge among the general Kuwaiti population. Hence, this study was performed to assess the level of knowledge towards CVD types, warning symptoms of heart attack or stroke, and CVD risk factors. It also explored public views on the community pharmacists' role in CVD prevention and management.

Methods: A descriptive cross-sectional survey was performed using a pretested self-administered questionnaire on a sample of 900 randomly selected Kuwaiti individuals. Descriptive and multivariate logistic regression analysis were used in data analysis.

Results: The response rate was 90.7%. Respondents' knowledge about types of CVD, heart attack or stroke symptoms was low. Almost 60% of respondents did not know any type of CVD, and coronary heart disease was the commonest identified type (29.0%). Two-fifths of participants were not aware of any heart attack symptoms, and the most commonly known were chest pain (50.4%) and shortness of breath (48.0%). Approximately half of respondents did not recognize any stroke symptoms, and the most commonly recognized were 'confusion or trouble speaking' (36.4%) and 'numbness or weakness' (34.7%). Respondents' knowledge regarding CVD risk factors was moderate. The commonest factors identified by over four-fifths of participants were smoking, obesity, unhealthy diet and physical inactivity. In the multivariate logistic regression analysis, independent predictors of better level of CVD knowledge were females, age 50-59 years, high level of education, regular eating of healthy diet, and had a family history of CVD. Most of respondents only identified the role that pharmacists had to play is to help patients manage their medications, with a minimal role in other aspects of CVD prevention and management.

Conclusions: There are deficiencies in CVD knowledge among Kuwaiti population, which could turn into insufficient preventative behaviours and suboptimal patient outcomes. There is an apparent need to establish more wide-spread and effective educational interventions, which should be sensitive to the perceptions, attitudes, and abilities of targeted individuals.

References

    1. World Health Organization: Cardiovascular diseases.
    1. World Health Organization: Cardiovascular diseases (CVDs): Fact sheet No. 317.
    1. Zubaid M, Rashed WA, Husain M, Mohammad BA, Ridha M, Basharuthulla M, Rezq MA, Smid J, Thalib L. A registry of acute myocardial infarction in Kuwait: patient characteristics and practice patterns. Can J Cardiol. 2004;20:783–787.
    1. World Health Organization:: World Health Statistics - Kuwait: country profiles -noncommunicable diseases.
    1. Alarouj M, Bennakhi A, Alnesef Y, Sharifi M, Elkum N. Diabetes and associated cardiovascular risk factors in the State of Kuwait: the first national survey. Int J Clin Pract. 2013;67:89–96. doi: 10.1111/ijcp.12064.
    1. International Diabetes Federation: IDF diabetes atlas: sixth edition.
    1. Pearson TA, Palaniappan LP, Artinian NT, Carnethon MR, Criqui MH, Daniels SR, Fonarow GC, Fortmann SP, Franklin BA, Galloway JM, Goff DC, Jr, Heath GW, Frank AT, Kris-Etherton PM, Labarthe DR, Murabito JM, Sacco RL, Sasson C, Turner MB. American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation. 2013;127:1730–1753. doi: 10.1161/CIR.0b013e31828f8a94.
    1. Becker MH, Maiman LA, Kirscht JP, Haefner DP, Drachman RH. The Health Belief Model and prediction of dietary compliance: a field experiment. J Health Soc Behav. 1977;18:348–366. doi: 10.2307/2955344.
    1. Ford ES, Jones DH. Cardiovascular health knowledge in the United States: findings from the National Health Interview Survey, 1985. Prev Med. 1991;20:725–736. doi: 10.1016/0091-7435(91)90067-E.
    1. McKinley S, Dracup K, Moser DK, Ball C, Yamasaki K, Kim CJ, Barnett M. International comparison of factors associated with delay in presentation for AMI treatment. Eur J Cardiovasc Nurs. 2004;3:225–230. doi: 10.1016/j.ejcnurse.2004.06.004.
    1. Sug Yoon S, Heller RF, Levi C, Wiggers J, Fitzgerald PE. Knowledge of stroke risk factors, warning symptoms, and treatment among an Australian urban population. Stroke. 2001;32:1926–1930. doi: 10.1161/01.STR.32.8.1926.
    1. Jafary FH, Aslam F, Mahmud H, Waheed A, Shakir M, Afzal A, Qayyum MA, Akram J, Khan IS, Haque IU. Cardiovascular health knowledge and behavior in patient attendants at four tertiary care hospitals in Pakistan–a cause for concern. BMC Public Health. 2005;5:124. doi: 10.1186/1471-2458-5-124.
    1. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germanò G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Eur J Prev Cardiol. 2012;19:585–667. doi: 10.1177/2047487312450228.
    1. Al Hamarneh YN, Crealey GE, McElnay JC. Coronary heart disease: health knowledge and behaviour. Int J Clin Pharm. 2011;33:111–123. doi: 10.1007/s11096-010-9467-9.
    1. Gill R, Chow CM. Knowledge of heart disease and stroke among cardiology inpatients and outpatients in a Canadian inner-city urban hospital. Can J Cardiol. 2010;26:537–540. doi: 10.1016/S0828-282X(10)70468-2.
    1. Khan MS, Jafary FH, Jafar TH, Faruqui AM, Rasool SI, Hatcher J, Chaturvedi N. Knowledge of modifiable risk factors of heart disease among patients with acute myocardial infarction in Karachi, Pakistan: a cross sectional study. BMC Cardiovasc Disord. 2006;6:18. doi: 10.1186/1471-2261-6-18.
    1. Mazloomy SS, Baghianimoghadam MH, Ehrampoush MH, Baghianimoghadam B, Mazidi M, Mozayan MR. A study of the knowledge, attitudes, and practices (KAP) of the women referred to health centers for cardiovascular disease (CVDs) and their risk factors. Health Care Women Int. 2014;35:50–59. doi: 10.1080/07399332.2012.755980.
    1. Saeed O, Gupta V, Dhawan N, Streja L, Shin JS, Ku M, Bhoi S, Verma S. Knowledge of modifiable risk factors of Coronary Atherosclerotic Heart Disease (CASHD) among a sample in India. BMC Int Health Hum Rights. 2009;9:2. doi: 10.1186/1472-698X-9-2.
    1. Kamran S, Bener AB, Deleu D, Khoja W, Jumma M, Al Shubali A, Inshashi J, Sharouqi I, Al Khabouri J. The level of awareness of stroke risk factors and symptoms in the Gulf Cooperation Council countries: Gulf Cooperation Council stroke awareness study. Neuroepidemiology. 2007;29:235–242. doi: 10.1159/000112856.
    1. Mukattash TL, Shara M, Jarab AS, Al-Azzam SI, Almaaytah A, Al Hamarneh YN. Public knowledge and awareness of cardiovascular disease and its risk factors: a cross-sectional study of 1000 Jordanians. Int J Pharm Pract. 2012;20:367–376. doi: 10.1111/j.2042-7174.2012.00208.x.
    1. Li YQ, Wright SC. Risk factors for cardiovascular disease in the Ga-Rankuwa community. Curationis. 2007;30:79–87. doi: 10.4102/curationis.v30i4.1120.
    1. Vaidya ARAU, Krettek A. Cardiovascular health knowledge, attitude and practice/behaviour in an urbanising community of Nepal: a population-based cross-sectional study from Jhaukhel-Duwakot Health Demographic Surveillance Site. BMJ Open. 2013;3:e002976. doi: 10.1136/bmjopen-2013-002976.
    1. Zhang QT, Hu DY, Yang JG, Zhang SY, Zhang XQ, Liu SS. Public knowledge of heart attack symptoms in Beijing residents. Chin Med J (Engl) 2007;120:1587–1591.
    1. Reeves MJ, Rafferty AP, Aranha AA, Theisen V. Changes in knowledge of stroke risk factors and warning signs among Michigan adults. Cerebrovasc Dis. 2008;25:385–391. doi: 10.1159/000121338.
    1. Attarchi M, Mohammadi S, Nojomi M, Labbafinejad Y. Knowledge and practice assessment of workers in a pharmaceutical company about prevention of coronary artery disease. Acta Med Iran. 2012;50:697–703.
    1. Kuwait Central Statistical Bureau: General population census.
    1. Dupont WD, Plummer WD Jr: Power and sample size calculations.
    1. Avis NE, Smith KW, McKinlay JB. Accuracy of perceptions of heart attack risk: what influences perceptions and can they be changed? Am J Public Health. 1989;79:1608–1612. doi: 10.2105/AJPH.79.12.1608.
    1. Petricek G, Vrcic-Keglevic M, Vuletic G, Cerovecki V, Ozvacic Z, Murgic L. Illness perception and cardiovascular risk factors in patients with type 2 diabetes: cross-sectional questionnaire study. Croat Med J. 2009;50:583–593. doi: 10.3325/cmj.2009.50.583.
    1. White CW, Albanese MA. Changes in cardiovascular health knowledge occurring from childhood to adulthood. A cross-sectional study. Circulation. 1981;63:1110–1115. doi: 10.1161/01.CIR.63.5.1110.
    1. Thanavaro JL, Moore SM, Anthony MK, Narsavage G, Delicath T. Predictors of poor coronary heart disease knowledge level in women without prior coronary heart disease. J Am Acad Nurse Pract. 2006;18:574–581. doi: 10.1111/j.1745-7599.2006.00174.x.
    1. Awad A, Abahussain E. Health promotion and education activities of community pharmacists in Kuwait. Pharm World Sci. 2010;32:146–153. doi: 10.1007/s11096-009-9360-6.
    1. International Pharmaceutical Federation: FIP Statement of policy- The role of the Pharmacist in the prevention and treatment of Chronic Disease.
    1. George J, McNamara K, Stewart K. The roles of community pharmacists in cardiovascular disease prevention and management. Australas Med J. 2011;4:266–272. doi: 10.4066/AMJ.2011.698.
    1. Altowaijri A, Phillips CJ, Fitzsimmons D. A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease. J Manag Care Pharm. 2013;19:408–416.
    1. Bell JS, Väänänen M, Ovaskainen H, Närhi U, Airaksinen MS. Providing patient care in community pharmacies: practice and research in Finland. Ann Pharmacother. 2007;41:1039–1046. doi: 10.1345/aph.1H638.
Pre-publication history
    1. The pre-publication history for this paper can be accessed here:

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi